New progress in non-drug therapy for gastroesophageal reflux disease

doi:10.3877/cma.j.issn.1674-392X.2020.04.003

Abstract

Abstract:

Gastroesophageal reflux disease (GERD) is a common gastrointestinal disease, which major treatment is medication therapy, such as pump proton inhibitors (PPIs). However, PPIs are limited in GERD treatment. Therefore, with the development of endoscopic and laparoscopic techniques, patients with GERD can choose endoscopic therapies or surgeries to cure the disease. New progress in endoscopic therapies (radiofrequency therapies, peroral endoscopic cardial constriction, anti-reflux mucosectomy, endoscopic fundoplication) and laparoscopic fundoplication will be elaborated in this review.

Key words: Gastroesophageal reflux disease, Endoscopic therapies, Radiofrequency therapies, Laparoscopic fundoplication

Xue Wei, Di Lu, Jianyu Hao. New progress in non-drug therapy for gastroesophageal reflux disease[J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2020, 14(04): 331-335.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhshfbwkzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-392X.2020.04.003

https://zhshfbwkzz.cma-cmc.com.cn/EN/Y2020/V14/I04/331

References 39

[1]	El-Serag HB, Sweet S, Winchester CC, et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review[J]. Gut, 2014, 63(6): 871-880.
[2]	Subramanian CR, Triadafilopoulos G. Refractory gastroesophageal reflux disease[J]. Gastroenterol Rep(Oxf), 2015, 3(1): 41-53.
[3]	El-Serag H, Becher A, Jones R. Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies[J]. Aliment Pharmacol Ther2010, 32(6): 720-737.
[4]	Ito T, Jensen RT. Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesium[J]. Curr Gastroenterol Rep, 2010, 12(6): 448-457.
[5]	Lo WK, Chan WW. Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis[J]. Clin Gastroenterol Hepatol, 2013, 11(5): 483-490.
[6]	Zirk-Sadowski J, Masoli JA, Delgado J, et al. Proton-pump inhibitors and long-term risk of community-acquired pneumonia in older adults[J]. J Am Geriatr Soc, 2018, 66(7): 1332-1338.
[7]	Hung YP, Lee JC, Tsai BY, et al. Risk factors of Clostridium difficile-associated diarrhea in hospitalized adults: Vary by hospitalized duration[J/OB]. J Microbiol Immunol Infect, 2019, S1684-1182(19)30088-X.
[8]	Fry LC, Mönkemüller K, Malfertheiner P. Systematic review: endoluminal therapy for gastro-oesophageal reflux disease: evidence from clinical trials[J]. Eur J Gastroenterol Hepatol, 2007, 19(12): 1125-1139.
[9]	Tam WC, Schoeman MN, Zhang Q, et al. Delivery of radiofrequency energy to the lower oesophageal sphincter and gastric cardia inhibits transient lower oesophageal sphincter relaxations and gastro-oesophageal reflux in patients with reflux disease[J]. Gut, 2003, 52(4): 479-485.
[10]	Hummel K, Richards W. Endoscopic treatment of gastroesophageal reflux disease[J]. Surg Clin North Am, 2015, 95(3): 653-667.
[11]	Viswanath Y, Maguire N, Obuobi RB, et al. Endoscopic day case antireflux radiofrequency(Stretta) therapy improves quality of life and reduce proton pump inhibitor(PPI) dependency in patients with gastro-oesophageal reflux disease: a prospective study from a UK tertiary centre[J]. Frontline Gastroenterol, 2019, 10(2): 113-119.
[12]	Liu PP, Meng QQ, Lin H, et al. Radiofrequency ablation is safe and effective in the treatment of Chinese patients with gastroesophageal reflux disease: A single-center prospective study[J]. J Dig Dis, 2019, 20(5): 229-234.
[13]	Liang WT, Wang ZG, Wang F, et al. Long-term outcomes of patients with refractory gastroesophageal reflux disease following a minimally invasive endoscopic procedure: a prospective observational study[J]. BMC Gastroenterol, 2014, 14: 178.
[14]	Noar M, Squires P, Noar E, et al. Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: a decade later[J]. Surg Endosc, 2014, 28(8): 2323-2333.
[15]	Kalapala R, Shah H, Nabi Z, et al. Treatment of gastroesophageal reflux disease using radiofrequency ablation(Stretta procedure): An interim analysis of a randomized trial[J]. Indian J Gastroenterol, 2017, 36(5): 337-342.
[16]	Coron E, Sebille V, Cadiot G, et al. Clinical trial: Radiofrequency energy delivery in proton pump inhibitor-dependent gastro-oesophageal reflux disease patients[J]. Aliment Pharmacol Ther, 2008, 28(9): 1147-1158.
[17]	He S, Xu F, Xiong X, et al. Stretta procedure versus proton pump inhibitors for the treatment of nonerosive reflux disease: A 6-month follow-up[J]. Medicine(Baltimore), 2020, 99(3): e18610.
[18]	Perry KA, Banerjee A, Melvin WS. Radiofrequency energy delivery to the lower esophageal sphincter reduces esophageal acid exposure and improves GERD symptoms: a systematic review and meta-analysis[J]. Surg Laparosc Endosc Percutan Tech, 2012, 22(4): 283-288.
[19]	Fass R, Cahn F, Scotti DJ, et al. Systematic review and meta-analysis of controlled and prospective cohort efficacy studies of endoscopic radiofrequency for treatment of gastroesophageal reflux disease[J]. Surg Endosc, 2017, 31(12): 4865-4882.
[20]	Lipka S, Kumar A, Richter JE. No evidence for efficacy of radiofrequency ablation for treatment of gastroesophageal reflux disease: a systematic review and meta-analysis[J]. Clin Gastroenterol Hepatol, 2015, 13(6): 1058-1067. e1.
[21]	Triadafilopoulos G. Stretta: a valuable endoscopic treatment modality for gastroesophageal reflux disease[J]. World J Gastroenterol, 2014, 20(24): 7730-7738.
[22]	Li X, Zhang XB, Hu HQ, et al. Effect and safety of peroral endoscopic cardial constriction for gastroesophageal reflux disease[J]. Chin Med J(Engl), 2017, 130(14): 1749-1750.
[23]	Hu HQ, Li HK, Xiong Y, et al. Peroral endoscopic cardial constriction in gastroesophageal reflux disease[J]. Medicine (Baltimore), 2018, 97(15): e0169.
[24]	Satodate H, Inoue H, Yoshida T, et al. Circumferential EMR of carcinoma arising in Barrett's esophagus: case report[J]. Gastrointest Endosc, 2003, 58(2): 288-292.
[25]	Patil G, Dalal A, Maydeo A. Feasibility and outcomes of anti-reflux mucosectomy for proton pump inhibitor dependent gastroesophageal reflux disease: First Indian study(with video)[J]. Dig Endosc, 2020, 32(5): 745-752.
[26]	Inoue H, Ito H, Ikeda H, et al. Anti-reflux mucosectomy for gastroesophageal reflux disease in the absence of hiatus hernia: a pilot study[J]. Annals of gastroenterology, 2014, 27(4): 346-351.
[27]	Sumi K, Inoue H, Kobayashi Y, et al. Endoscopic treatment of proton pump inhibitor-refractory gastroesophageal reflux disease with anti-reflux mucosectomy: Experience of 109 cases[J]. Dig Endosc, 2020, DOI: 10.1111/den.13727.
[28]	Trad KS, Barnes WE, Prevou ER, et al. The TEMPO Trial at 5 Years: Transoral Fundoplication(TIF 2.0) Is Safe, Durable, and Cost-effective[J]. Surg Innov, 2018, 25(2): 149-157.
[29]	Testoni PA, Testoni S, Distefano G, et al. Transoral incisionless fundoplication with EsophyX for gastroesophageal reflux disease: clinical efficacy is maintained up to 10 years[J]. Endosc Int Open, 2019, 7(5): E647-E654.
[30]	Zacherl J, Roy-Shapira A, Bonavina L, et al. Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSE) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial[J]. Surg Endosc, 2015, 29(1): 220-229.
[31]	Kim HJ, Kwon CI, Kessler WR, et al. Long-term follow-up results of endoscopic treatment of gastroesophageal reflux disease with the MUSE endoscopic stapling device[J]. Surg Endosc, 2016, 30(8): 3402-3408.
[32]	Richards WO, Houston HL, Torquati A, et al. Paradigm shift in the management of gastroesophageal reflux disease[J]. Ann Surg, 2003, 237(5): 638-647.
[33]	Liang WT, Wu JM, Hu ZW, et al. Laparoscopic Nissen fundoplication is more effective in treating patients with GERD-related chronic cough than Stretta radiofrequency[J]. Minerva Chir, 2014, 69(3): 121-127.
[34]	Hu ZW, Wang ZG, Zhang Y, et al. A preliminary investigation of anti-reflux intervention for gastroesophageal reflux related childhood-to-adult persistent asthma[J]. Ann Surg Innov Res, 2014, 8: 3.
[35]	Liang WT, Wu JN, Wang F, et al. Five-year follow-up of a prospective study comparing laparoscopic Nissen fundoplication with Stretta radiofrequency for gastroesophageal reflux disease[J]. Minerva Chir, 2014, 69(4): 217-223.
[36]	Liang WT, Yan C, Wang ZG, et al. Early and Midterm outcome after laparoscopic fundoplication and a minimally invasive endoscopic procedure in patients with gastroesophageal reflux disease: a prospective observational Study[J]. J Laparoendosc Adv Surg Tech A, 2015, 25(8): 657-661.
[37]	Hu Z, Wu J, Wang Z, et al. Outcome of Stretta radiofrequency and fundoplication for GERD-related severe asthmatic symptoms[J]. Front Med, 2015, 9(4): 437-443.
[38]	Yan C, Liang WT, Wang ZG, et al. Comparison of Stretta procedure and toupet fundoplication for gastroesophageal reflux disease-related extra-esophageal symptoms[J]. World J Gastroenterol, 2015, 21(45): 12882-12887.
[39]	Zhang C, Wu J, Hu Z, et al. Diagnosis and anti-reflux therapy for gerd with respiratory symptoms: a study using multichannel intraluminal impedance-pH monitoring[J]. PLoS One, 2016, 11(8): e0160139.

Please choose a citation manager

Content to export